Cramer’s lightning round: There’s really no reason to recommend Snap here

Cramer’s lightning round: There’s really no reason to recommend Snap here


Rhythm Pharmaceuticals: “Very interesting company. Does weight loss, but I’ve got a company that does weight loss and a lot of other things and it’s called Eli Lilly. It is owned by my Charitable Trust, and we talk about it a lot with the Investing Club.”

Snap: “I have no reason to buy Snap — it is losing money — other than the fact it’s a $10 stock. I can’t make that be the only reason why I recommend the stock.

Vista Outdoor: “You know, Vista Outdoor if you actually got rid of the guns — I am a hunter — if you got rid of the guns and had just all the other stuff, I think the stock would be higher because that’s the world we’re in. Not saying it’s a good world, bad world, but it is the world we’re in.”

Eagle Bulk Shipping: “All the bulk shippers have the same problem. They’ve got these giant yields, but I’m telling you, they are not worth it. I don’t like the risk. I don’t like the risk.”

Disclosure: Cramer’s Charitable Trust owns shares of LLY.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More
Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices
Business

Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices

A customer shops for Halloween candy at a Walmart Supercenter on October 16, 2024 in Austin, Texas.  Brandon Bell | Getty Images The scariest thing haunting Halloween this year isn’t a ghost, goblin or ghoul — it’s the price of chocolate. From Snickers to Reese’s to Twix, one of America’s favorite indulgences is getting more […]

Read More